Status:
COMPLETED
Prospective Evaluation of Reverse End to Side Anterior Interosseous Nerve to Ulnar Nerve Transfer for Severe Compressive Ulnar Neuropathy at the Elbow
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Dr Christopher Doherty
Dr Thomas Miller
Conditions:
Severe Compressive Ulnar Nerve Neuropathy (McGowan Grade III)
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
Ulnar nerve compression at the elbow is a common problem and can significantly affect hand function in severe cases. The current, standard treatment is Ulnar nerve decompression with or without transp...
Detailed Description
The purpose of this study is to prospectively compare the outcomes of patients with severe (intrinsic hand muscle dysfunction) compressive ulnar neuropathy at the elbow treated with ulnar nerve decomp...
Eligibility Criteria
Inclusion
- Adult patients (greater than 18 years) with severe compressive ulnar nerve neuropathy (McGowan grade III) at the elbow who consent to either ulnar nerve decompression with transposition alone or ulnar nerve decompression with transposition plus nerve transfer.
Exclusion
- Patients under the age of 18 and over 70.
- Patients with ulnar neuropathy at multiple anatomic locations along the course of the nerve.
- Patients with mild to moderate ulnar neuropathy (McGowan grade I and II).
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02281656
Start Date
January 1 2015
End Date
October 1 2016
Last Update
November 6 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.